Teriparatide acetate hydrate structure
|
Common Name | Teriparatide acetate hydrate | ||
---|---|---|---|---|
CAS Number | 99294-94-7 | Molecular Weight | 4177.83 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C181H291N55O51S2.x(C2H4O2).x(H2O) | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Teriparatide acetate hydrateTeriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) is a PHT agonist. Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) can be used for osteoporosis research[1]. |
Name | Teriparatide acetate hydrate |
---|---|
Synonym | More Synonyms |
Description | Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) is a PHT agonist. Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) can be used for osteoporosis research[1]. |
---|---|
Related Catalog | |
In Vivo | Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity[1]. Animal Model: Female New Zealand white rabbits[1] Dosage: 20 μg/kg Administration: Subcutaneous injection; daily, for 4 weeks Result: Increased the pore ratio, number, and density as well as the cortical area, thickness, and bone mineral content (BMC), without significant influencing the volumetric bone mineral density (BMD). |
References |
Molecular Formula | C181H291N55O51S2.x(C2H4O2).x(H2O) |
---|---|
Molecular Weight | 4177.83 |
Storage condition | -20°C |
Hazard Codes | Xi |
---|
MFCD01775001 |